Paolo Pucci insider trades
Open-market stock purchases and sales by Paolo Pucci, Director at West Pharmaceutical Services Inc, from SEC Form 4 filings since Jan 20, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 4, 2026 | WST West Pharmaceutical Services Inc | Bought (not open market) | — |
| Apr 1, 2026 | REPL Replimune Group, Inc | Bought (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
| Dec 12, 2025 | MRUS Merus NV | Sold (not open market) | — |
Companies traded
- WST West Pharmaceutical Services Inc: other filings, last May 4, 2026
- REPL Replimune Group, Inc: other filings, last Apr 1, 2026
- MRUS Merus NV: other filings, last Dec 12, 2025
- TRIL Trillium Therapeutics Inc: other filings, last Nov 17, 2021
- ARQL Arqule Inc: 20 buys, last Jan 16, 2020
- (NLNK) Newlink Genetics Corp: other filings, last May 23, 2018
- DYAX Dyax Corp: 1 sale, last Jan 22, 2016